Other languages Sandu Pharmaceuticals Limited

Equities

SANDUPHQ6

INE751D01014

Market Closed - Bombay S.E. Other stock markets 06:00:52 2024-05-30 EDT			5-day change	1st Jan Change
59.67 ^INR	+2.05%		-0.48%	-12.38%

03-30	Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer	CI
03-30	Sandu Pharmaceuticals Limited Announces Executive Changes	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sandu Pharmaceuticals Limited Announces Executive Changes	03-30
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14
Sandu Pharmaceuticals' Consolidated Net Profit Slips in Fiscal Q2	11-14
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-13
Sandu Pharmaceuticals Limited Approves Change in Directorate	23-09-30
Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-09-06
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31St March 2023	23-08-14
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14
Sandu Pharmaceuticals Limited Enters into Memorandum of Understanding with Bach Ma Van Xuan Pharmaceuticals	22-12-10
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14
Sandu Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022	22-10-01
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31 March 2022	22-08-12
Sandu Pharmaceuticals Limited Incorporates Subsidiary	22-07-27
Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-30
Sandu Pharmaceuticals Limited Announces Formation of A Wholly Owned Subsidiary Company	22-02-14
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14
Sandu Pharmaceuticals Limited Approves Appointment of K Vinay Kumar as Chairman	22-02-14
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-13
Sandu Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2021	21-08-14
Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sandu Pharmaceuticals Limited

Equities

SANDUPHQ6

INE751D01014

Other languages

Filters